Search PubMed⌕ Search

Biomedical subjects

K Asano

Publications and source records attributed to K Asano.

At least 469 records · Page 26Linked to original sources

Beta-adrenergic blockade and training in healthy men--effects on central circulation.

The effect of chronic beta-adrenergic blockade on central circulatory adaptations to physical training was investigated. 16 healthy sedentary males (20-31 yrs) trained on cycle ergometers 40 min/day, 4 days a week for 8 weeks at a work load that during the last 5 weeks corresponded to 75% of the pretraining VO2 max. In a single blind way, 8 subjects were during the training period treated with the beta-adrenergic receptor blocker propranolol (160 mg/day), while the remaining 8 received placebo tablets. Pretraining tests were performed before the start of medication and posttraining tests were performed 6 days after the last day of training and medication. The training program resulted in a similar increase (8%) in VO2 max in both groups (p less than 0.01). The resting heart rate (-4 beats/min; p less than 0.05) as well as the exercise heart rate at a moderate work load (120 W: -11 beats/min; p less than 0.01) decreased with training, and no significant difference was seen between the 2 groups. At a high work load (180 W), however, the heart rate decreased significantly more with training in the placebo group as compared with the beta-blockade group (-19 vs. -7 beats/min; p less than 0.05). The oxygen pulse (VO2/HR) increased in both groups at 120 W (+6%; p less than 0.01). At 180 W the oxygen pulse increased only in the placebo group (+8%; p less than 0.05). The estimated stroke volume at 120 and 180 W, as determined by impedance cardiography, did not change significantly with training although there was a tendency towards an increase in the placebo group only. The resting left ventricular wall thickness and diameter, as determined by echocardiography, did not change significantly with training in either group.--In conclusion, the present study indicates that a moderate degree of beta-adrenergic blockade does not prevent or impair the training-induced increase in the maximal oxygen uptake. During submaximal work, however, the circulatory adaptation may be less apparent if training has been performed during partial blockade of the sympatho-adrenal system.

Adaptation, Physiological↗

Intravenous leiomyomatosis of the uterus with continuous extension into the pulmonary artery.

A 56-year-old woman presented with an intracardiac tumor, as shown by two-dimensional echocardiography. Surgical treatment, undertaken in two stages, revealed a tumor which arose in the uterus, passed through both ovarian veins, the inferior vena cava, the right atrium and ventricle, and the pulmonary trunk, and extended to both pulmonary arteries. The upper portion of the tumor was removed in the first surgical operation, and the remaining tumor was removed during a second operation 1 year later. Both specimens were identical in appearance, and a pathohistological diagnosis of benign leiomyoma was made.

Echocardiography↗

Oxygen deficit and anaerobic threshold in the incremental exercise in normoxia and hypoxia.

The differences between VO2 at the 5th min in steady state exercise and VO2 in incremental exercise were consecutively added from start of incremental exercise to a given time. These added values were defined as oxygen deficit. Anaerobic threshold was determined as the breakpoint of blood lactate during incremental exercise. The oxygen deficit at the anaerobic threshold in normoxia was almost identical to that in hypoxia.

Adult↗

[Treatment of esophageal cancer by endoscopic administration of peplomycin ointment].

Pepleomycin ointment was developed to improve the antitumor activity afforded by endoscopic therapy for esophageal cancer. Through the esophagoscope we could observe this ointment specifically attacking the lesion. Furthermore we were able to recognize that peplomycin was acting directly on the lymph nodes as well as the tumor in a resected portion of the esophagus. It is hopefully anticipated that this method will be used as a combination therapy in pre-operative and inoperable esophageal cancer.

Aged↗

Aclarubicin in the treatment of multiple myeloma.

Fourteen patients with multiple myeloma received aclarubicin (ACR) intravenous drip infusion at a dose of 15-25 mg/m2/day for 7 days every 3 weeks. Nine of the patients achieved more than a 25% reduction in M-protein. In two of the nine the reduction was more than 50% and the duration of their responses was 2.0 and 2.8 months, respectively. In the nine cases of previous combination chemotherapy-resistant multiple myeloma, five showed more than a 25% reduction and one of them showed more than a 50% reduction in M-protein. One of the two patients with tumors achieved a marked regression of the tumor mass and two of the 14 patients showed marked improvement in subjective symptoms. Hematological toxicity, anorexia, nausea and vomiting occurred frequently. However, no cardiac toxicity obviously attributable to ACR was detected, and alopecia was generally mild. Thus, the above results indicate that ACR may be useful in combination chemotherapy for multiple myeloma because of its effectiveness and relatively low dose-limiting factors.

Aclarubicin↗